Product/Composition:- | Sorafenib |
---|---|
Strength:- | 200 mg |
Form:- | Film Coated Tablet |
Reference Brands:- | Nexavar (EU & US) |
MOQ | As per the manufacturer batch size |
Get Quote Send Enquiry on WhatsApp |
Sorafenib Tablets 200 mg are oral oncology drugs used to treat liver, kidney, and thyroid cancers. Approved in the U.S. and EU, they are essential for targeted cancer therapy and available under Nexavar and generics for B2B distribution.
Sorafenib Tablets 200 mg are a key oncology treatment used in the management of advanced cancers such as hepatocellular carcinoma (HCC), renal cell carcinoma (RCC), and differentiated thyroid carcinoma refractory to radioactive iodine. As a multikinase inhibitor, Sorafenib targets tumor cell proliferation and angiogenesis, making it effective in slowing cancer progression. Approved in both the U.S. and EU under the brand name Nexavar, with multiple generic versions available, Sorafenib is a vital product for pharmaceutical B2B distribution. Available in 200 mg film-coated tablets, it meets global oncology standards and supports hospitals and cancer centers in advanced cancer care.
Embrace a platform that empowers you to invest in gold online effortlessly, making the path to financial growth accessible to everyone.
Get access to the finest pharmacy products with a NazarethPharmacy.com. They offer comprehensive worldwide pharmacy services, making them your best choice for online medications